病因和临床结果的患者谁未能查跨导管三管干预措施的原因和临床结果
Ghadi Moubarak1, Austin Kluis1, John Eisenga1
1Baylor Scott and White Research Institute Plano, Texas.
The American journal of cardiology
|April 6, 2024
概括
无法接受过导管三门干预 (TTVI) 的患者往往表现不佳,特别是那些有解剖学限制的患者. 对于这个群体,需要进一步的透导管疗法.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏门疾病 心脏门疾病
背景情况:
- 透导管三门干预 (TTVI) 是一种针对三门吐 (TR) 的新疗法.
- 许多患者被排除在TTVI试验之外,他们的结果被了解得很少.
研究的目的:
- 为了确定TTVI屏幕故障的原因.
- 为了评估TTVI下降的患者的自然史和结果.
主要方法:
- 对32名不符合TTVI试验条件的患者进行了回顾性单中心研究.
- 患者被分为优化医疗疗 (OMT) 或干预组.
- 对人口统计数据,排除原因和1年临床结果的分析.
主要成果:
- 常见的排除原因包括解剖/程序障碍 (53.1%) 和未满足的纳入标准 (40.6%).
- 仅接受OMT治疗的患者的一年复合结局为47.4% (心脏病死亡/心力衰竭再入院).
- 与干预组相比,OMT组的结果更差 (47.7%对23.1%,p=0.3),特别是对那些有解剖学限制的人来说 (70%对14.3%,p=0.05).
结论:
- 无法接受TTVI的患者,特别是那些有解剖学/程序限制的患者,仅用医疗治疗就会经历糟糕的结果.
- 这些发现凸显了需要更早地转诊患者,以及为TR开发先进的透导管疗法.
相关概念视频
01:27Pneumothorax-II
141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
141
01:17Imaging Studies for Cardiovascular System I:Echocardiography
320
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
320